Latent tuberculosis infection in travelers: Is there a role for screening using interferon-gamma release assays?

Journal of Travel Medicine

Volumn 16, Issue 5, 2009, Pages 352-356

  Ingram, Paul R ^a,b   Fisher, Dale A ^a,b   Wilder Smith, Annelies ^a,b  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

HUMAN; IMMUNOASSAY; INFECTION RISK; LATENT PERIOD; MULTIDRUG RESISTANT TUBERCULOSIS; REVIEW; SCREENING; TRAVEL; TUBERCULOSIS;

DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TRAVEL;

EID: 70349229391     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2009.00315.x     Document Type: Review

References (39)

1. Mandell G, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 6th Ed. Philadelphia : Elsevier, 2005.
2. Cobelens F, Van Deutekom H, Draayer-Jansen I, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000 356 : 461 465.
3. Anonymous. Tuberculosis screening and the international traveller. Can Commun Dis Rep 1996 22 : 149 155.
4. Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004 350 : 2060 2067.
5. Varkey P, Jerath A, Bagniewski B, et al. The epidemiology of tuberculosis among primary refugee arrivals in Minnesota between 1997 and 2001. J Travel Med 2007 14 : 1 8.
6. Cobelens F, Van Deutekom H, Draayer-Jansen I, et al. Association of tuberculin sensitivity in Dutch adults with history of travel to areas of with a high incidence of tuberculosis. Clin Infect Dis 2001 33 : 300 304.
7. Sepkowitz KA. Tuberculin skin testing and the health care worker: lessons of the Prophit Survey. Tuber Lung Dis 1996 77 : 81 85.
8. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976 19 : 1 63.
9. Lobato MN, Hopewell PC. Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 1998 158 : 1871 1875.
10. Houston S. Tuberculosis risk and prevention in travelers - what about BCG? J Travel Med 1997 4 : 76 82.
11. Jung P, Banks R. Tuberculosis risk in US Peace Corps volunteers, 1996 to 2005. J Travel Med 2008 15 : 87 94.
12. Wilder-Smith A, Foo W, Earnest A. High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage. Trop Med Int Health 2005 10 : 336 339.
13. Cauthen G, Pio A, ten Dam H. Annual risk of tuberculous infection. 1988. Bull World Health Organ 2002 80 : 503 511.
14. Leder K, Tong S, Weld L, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel surveillance network. Clin Infect Dis 2006 43 : 1185 1193.
15. Shah S, Tanowitz H, Wittner M. The ethnic minority traveler. Infect Dis Clin North Am 1998 12 : 523 534.
16. Virk A. Medical advice for international travelers - reply. Mayo Clin Proc 2001 76 : 1275 1279.
17. Selwyn P, Hartel D, Lewis V, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989 320 : 545 550. (Pubitemid 19070537)
18. Horsburgh C, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 2000 31 : 633 639.
19. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control Online 2006. Available at : http://www.nice.org.uk/ guidance/index.jsp?action=download&o=30019. (Accessed 2008 Aug 11)
20. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000 161 : S221 S247.
21. Kwara A, Herold J, Machan J, et al. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island. Chest 2008 133 : 862 868.
22. World Health Organization. The Global MDR-TB & XDR-TB Response Plan 2007-2008 Online 2007. Available at : http://whqlibdoc.who.int/hq/2007/WHO-HTM- TB-2007.387-eng.pdf. (Accessed 2008 Aug 11)
23. Rieder HL. Risk of travel-associated tuberculosis. Clin Infect Dis 2001 33 : 1393 1396.
24. Lifson A. Prevention of travel-associated tuberculosis in the high risk traveler. Clin Infect Dis 2002 34 : 1163.
25. International travel and health. Geneva, Switzerland : WHO Press, 2007.
26. Arguin PM, Kozarsky PE, Reed C, eds. Centers for Disease Control and Prevention health information for international travel. Atlanta, GA : Elsevier, 2007.
27. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008 149 : 177 184.
28. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007 146 : 340 354.
29. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR Recomm Rep 2003 52 : 15 18.
30. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T-cell assay conversions and reversions? PLoS Med 2007 4 : 980 983.
31. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006 174 : 349 355.
32. Wilson JM, Jungner G. Principles and practice of screening for disease. Public Health Paper Number 34. Geneva, Switzerland : WHO, 1968.
33. Toovey S, Moerman F, van Gompel A. Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part II: infections other than malaria. J Travel Med 2007 14 : 50 60. (Pubitemid 46114987)
34. Anonymous. The risk and prevention of tuberculosis in travellers. Can Commun Dis Rep 1997 23 : 1 8.
35. Steele MA, Burk RF, Desprez RM. Toxic hepatitis with isoniazid and rifampicin. Chest 1991 99 : 465 471.
36. Diel R, Wrighton-Smith P, Zellweger JP. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. Eur Respir J 2007 30 : 321 332. (Pubitemid 47194185)
37. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007 11 : 16 26.
38. Rose D, Schechter C, Adler J. Interpretation of the tuberculin skin test. J Gen Intern Med 1995 10 : 635 642.
39. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005 54 : 1 141.